A Canadian company based in Ontario, coordinating patients into advanced regenerative medicine at Innovita Clinic in Vilnius, Lithuania.
By Jed Ryan, Founder and CEO · Reviewed by Adas Darinskas, PhD, Chief Science Officer · Published · Last reviewed
For Canadian patients, this is a domestic point of contact, a familiar conversation, and a clear pathway to treatments that are not yet broadly available in Canada.
This page covers what's most relevant for Canadian patients specifically. For the broader picture of treatments, the medical team, and the patient journey, see our main Lithuania guide.
The Canadian regulatory landscape for regenerative medicine is conservative compared to many international peers. Health Canada regulates cell therapies as drugs under the Food and Drugs Act, and most regenerative therapies (including MSC stem cell therapy and exosome therapy for orthopedic, autoimmune, and neurological indications) are not currently authorized for routine clinical use in Canada outside of approved clinical trials.
At the same time, Canadian patients are facing some of the longest healthcare wait times on record. The Fraser Institute's 2025 report on wait times found a national median of 28.6 weeks from GP referral to treatment, with orthopedic surgery at 48.6 weeks and neurosurgery at nearly 50 weeks. For patients in New Brunswick, total wait times exceed a year.
The result is that a growing number of Canadians are looking internationally for advanced regenerative options. We help make that decision an informed one.
In Canada, most cell therapies are considered investigational and require Health Canada authorization to be administered domestically. The exceptions are well-defined: established hematopoietic stem cell transplants for certain blood cancers, the approved CAR-T cell therapies, and the Health-Canada-approved MSC product Prochymal for pediatric graft-versus-host disease.
MSC therapies for orthopedic, autoimmune, and neurological conditions, exosome therapy, and most of the immunotherapy and longevity protocols offered at Innovita Clinic are not authorized for clinical use in Canada outside of clinical trials.
Canadian patients who pursue regenerative medicine internationally do so under the regulatory framework of the country where treatment is administered, in this case Lithuania and the European Union. This is a different framework, with different evidence, manufacturing, and authorization standards.
What this means in practice for Canadian patients:
Vilnius International Airport (VNO) is reached from Canada by one connection through major European hubs. Most patients fly via:
Typical total travel times from Canada:
For most Canadian patients, treatment is combined with a longer trip, typically 5-10 days total, depending on protocol.
For full travel detail (driver service, hotel recommendations, food, communication), see the main Lithuania guide.
Innovita Clinic offers immunotherapy, regenerative medicine, and longevity protocols. Each is detailed on its own page. The categories below cover what's available.
A highly specific population of mesenchymal stem cells, selected and cultured in low-oxygen conditions to strengthen their stress-enduring qualities. They're used to repair tissue, calm an overactive immune system, and bring down inflammation, and they're the backbone of most protocols we coordinate.
Learn MoreTiny vesicles released by stem cells that carry signals between your cells. They're studied for tissue repair and immune modulation, and they're small enough to cross the blood-brain barrier, which can be a real advantage for neurological conditions.
Learn MoreShort chains of amino acids that signal specific processes in the body. Depending on the peptide, that can mean faster tissue healing, restoring hormonal balance, modulating the immune system, sharper metabolism, deeper sleep, or clearer cognition. We source and coordinate the ones that fit what you're working on.
Learn MoreVitamins, minerals, and antioxidants delivered straight into the bloodstream, where your body can use them right away. We run it on its own or alongside stem cell, exosome, and peptide protocols to support energy, recovery, and resilience.
Learn MoreBiological products like cord blood plasma, placenta cryoprecipitate, and concentrated growth factors. Many are birth-tissue-derived, rich in the proteins, cytokines, and growth factors the body uses to restore cellular function. Used on their own or alongside a protocol.
Learn MorePeople are unique, and more often than not so are the conditions they're dealing with. So most plans pair more than one therapy. Dr. Darinskas and his team combine stem cells, exosomes, peptides, and biologics around your specific case.
View All TreatmentsPatients travelling internationally for treatment do so under the regulatory framework of the country where treatment is administered, not under Health Canada jurisdiction.